RevealRPI Therapeutics
RevealRPI Therapeutics is developing first-in-class cancer therapeutics that target disease-relevant RNA-protein interfaces, an emerging and underexplored drug modality.
)
January 11-14, 2027 | San Francisco
January 11-14, 2027 | San Francisco
)
)
January 11-14, 2027 | San Francisco
){kind=logo}
)